Dashboard
Financial statements
DHR

Company financials

Danaher Corporation

Health Care Life Sciences Tools & Services Washington, D.C. Last filing Feb 24, 2026 · FY2025
Revenue FY2025
$24.6B
3y CAGR -2.7% P10
Net income FY2025
$3.6B
Net margin +14.7% P63
Total assets FY2025
$83.5B
ROA +4.3% P36
Operating cash flow FY2025
$6.4B
FCF margin +21.4% P75
19 yrs · FY2007–FY2025 8 filed · 1 derived · 0 blank

Running CAGR since the earliest displayed year.

Balance Sheet

Assets, liabilities, and equity

24 accounts · 10 years
Total assets $83.5B
Total liabilities ~$30.9B
Shareholders equity $52.5B
Account 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 Trend
Assets
Cash and Cash Equivalents +19.0% +10.1% +29.4% +35.6% +21.8% +58.2% +174.4% -9.6% -34.6% —
Accounts Receivable +2.3% +1.3% +3.0% +4.3% +7.8% +6.1% +0.1% -2.5% +10.5% —
Inventory +4.3% +3.9% +6.1% +8.3% +10.1% +7.6% -1.6% -2.3% +7.7% —
Prepaid Expenses +8.9% +8.5% +9.9% +13.7% +15.6% +15.4% +2.4% +3.2% +6.4% —
Total Current Assets +7.5% +4.5% +11.1% +15.6% +11.8% +20.0% +56.6% +3.2% +2.8% —
Property,Plant and Equipment +10.0% +9.8% +9.9% +7.9% +10.0% +8.5% -0.7% -2.2% +4.3% —
Goodwill +6.8% +6.9% +8.3% +7.7% +11.6% +10.4% -1.6% -2.7% +5.5% —
Intangible Assets +4.7% +5.8% +8.4% +9.0% +14.1% +15.8% -6.2% -6.7% -1.3% —
Other Noncurrent Assets +23.5% +25.9% +28.5% +51.6% +42.6% +39.6% +39.7% +198.5% -14.7% —
Total Assets +7.0% +7.0% +9.3% +10.9% +12.9% +13.9% +11.1% +2.8% +3.0% —
Liabilities
Accounts Payable +2.4% +2.1% +2.5% +3.8% +11.6% +8.4% +0.7% +0.3% +1.7% —
Accrued Liabilities +6.6% +6.3% +8.1% +9.5% +14.8% +17.6% +4.7% -1.9% +10.5% —
Current Portion of Long Term Debt -54.9% -18.5% -5.9% -21.9% -68.5% -74.5% -56.6% -85.9% -92.5% —
Total Current Liabilities -0.1% -0.1% +2.7% +3.4% +3.4% +1.9% -10.5% -16.1% -30.3% —
Long Term Debt +7.4% +6.1% +8.1% +12.0% +18.0% +21.7% +30.5% +0.1% +6.8% —
Other Noncurrent Liabilities +0.1% +0.1% +0.9% +3.0% +6.3% +8.3% -1.9% -5.4% -9.0% —
Equity
Common Stock +1.2% +1.3% +1.5% +1.8% +2.1% +2.7% -0.4% +0.6% +0.0% —
Additional Paid In Capital +13.9% +15.4% +17.2% +14.7% +13.7% +16.2% +12.5% +4.8% +4.2% —
Retained Earnings +9.5% +9.9% +10.3% +11.2% +9.7% +7.0% +5.3% +10.2% +10.2% —
Treasury Stock — — — — — — — — — —
Accumulated Other Comprehensive Income — — — — — — — — — —
Total Stockholders Equity +9.6% +10.1% +12.8% +13.8% +14.4% +14.7% +9.6% +10.8% +14.6% —
Noncontrolling Interest -23.1% -25.5% -34.1% -31.0% -33.0% -37.9% -47.0% -59.2% -87.0% —
Total Liabilitiesand Equity +7.0% +7.0% +9.3% +10.9% +12.9% +13.9% +11.1% +2.8% +3.0% —

Key Ratios

Margins, returns, liquidity, leverage, efficiency

Computed at import · 10 years
Ratio 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Profitability
Gross margin +59.1% +59.5% +58.7% +60.8% +61.4% +56.0% +55.7% +55.8% +55.2% +55.3%
Operating margin +19.1% +20.4% +21.8% +28.3% +25.7% +19.0% +18.3% +17.9% +16.6% +16.2%
Net margin +14.7% +16.3% +19.9% +27.1% +25.9% +16.4% +16.8% +15.5% +16.1% +15.1%
FCF margin +21.4% +22.2% +24.2% +27.8% +28.7% +24.3% +18.5% +20.2% +18.7% +17.4%
Growth
Revenue CAGR (3y) -2.7% -1.3% +2.3% +14.2% +13.3% +12.8% +2.0% +5.7% +6.4% -2.6%
Returns
ROE +6.9% +7.9% +8.9% +14.4% +14.2% +9.2% +9.9% +9.4% +9.5% +11.1%
ROA +4.3% +5.0% +5.6% +8.5% +7.7% +4.8% +4.8% +5.5% +5.3% +5.6%
ROIC +6.0% +6.4% +6.6% +10.5% +8.2% +6.2% +7.5% +6.7% +6.1% +6.6%
Liquidity
Current ratio 1.87x 1.40x 1.68x 1.89x 1.43x 1.86x 5.19x 1.47x 1.43x 0.97x
Quick ratio 1.25x 0.83x 1.18x 1.20x 0.89x 1.36x 4.68x 0.79x 0.87x 0.60x
Leverage
D/E 0.59x 0.57x 0.58x 0.68x 0.84x 0.92x 1.05x 0.70x 0.77x 0.97x
Interest coverage 17.70x 17.49x 18.19x 36.94x 27.61x 15.39x 30.27x 22.30x 18.36x 14.83x
Efficiency
Asset turnover 0.29x 0.31x 0.28x 0.32x 0.30x 0.29x 0.29x 0.36x 0.33x 0.37x
Cash conversion cycle +82d +76d +91d +88d +76d +75d +70d +71d +100d +80d

Valuation

Price against fundamentals

FY2025 fundamentals · no price

No price data cached, so there is nothing to multiply. Load prices from the Stock Data tab and this panel reprices itself.

Notes

Your annotations

Not watched
Saving notes adds DHR to your watchlist.